Additionally, breast cancer subtypes, as defined by hormone receptor status and human epidermal growth factor receptor 2 (HER2) expression, did not show statistically significant association with the sensitivity of the three-protein signature (p = 0.902, Fig. 2b). The gene discussed is ERBB2; the disease is breast cancer.